You are here

Home » Content

SİROZLU HASTALARDA ANTIKARDIYOLIPIN ANTİKORLARI

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2000

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Anticardiolipin Antibodies in the Patients with Liver Cirrhosis. Antieardiolipin antibodies (ACA) have becn reported in numcrcous conditions apart from primary antihospholipid syndrome. In this study, we searehed presence of ACA in 25 cirrhotic patients. ACA levels of cİrrhotİc patients wcrc significantly highcr than controls. Number of thc patients who have high ACA IgG and IgM levels (at least +2 SD) were higher than controls. Tlıerc was no corre-lation betvvccn ACA levels and Child stages of thc ciırhoüc patients. We foutıd a poskive cor-relalion betwecn ACA and gammaglobulin levels. In conelusion, ACA levels have becn inere -ased in chxhotic patients, but this seems not to be related with stage and complİcations of cirrhosis. High ACA levels might be refleeting hypergammaglobulinemia seen in cirrhotic patients.
Bookmark/Search this post with
Abstract (Original Language): 
Antifosfolipid antikorları anüfosfolipid scndromuııun yamsıra, birçok hastalıkta yüksek bulunabilmektedir. Bu çalışmada karaciğer sirozlu 25 hastada antikardiyolîpin antikorlarının (AKA) varlığı vc kJinik ve biyoşimik parametrelerle ilişkisi araştırıldı. Hastaların ortalama AKA Ig G ve Ig M düzeyleri kontrol grubuna göre yüksek bulundu. AKA IgG ve IgM düzeyleri en az +2 standart sapma artmış olan hasta sayısı da kontrol grubuna göre daha fazla idi. AKA düzeyleri sirozun evresi ile ilişkili değildi. AKA düzeyleri gamma globulin düzeyleri ile pozitif korelasyon göstermekteydi. Sonuç olarak, sirozlu hastalarımızda AKA düzeyleri yükselmektedir ve bu yükseklik hastalığın evresi ve komplikasyonlan ile ilişkisiz gibi görünmektedir. AKA düzeylerindaki yükseklik sirozlu hastalarda görülen genel gammaglobulin artışının bir yansıması olabilir.
FULL TEXT (PDF): 
PDF icon arastirmax-sirozlu-hastalarda-antikardiyolipin-antikorlari.pdf
  • 2
142-146
  • Turkish

REFERENCES

References: 

1. Biron C, Andreani H, Blanc P, et al.: Prevalencc of an-liphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virüs: correlation with liver injury. J Lab din Med 131: 243 (1998).
2. Bithell TC. Acquircd coagulation disorders. '"VVintrobe's Clinicaİ Hematology, Editör Lee GR, Bithell TC, Foers-ler .(, et al., 9th ed., Lea and Febringer, Philadelphia". s:1473 (1993).
3. Clıakravarty KK, Gray RE, Webley M, Byron MA, VVoz-niak S: Prevalence of anticardio-lipin antibodies in the el-derly British population. Postgrad Med J 67: 358 (1991).
4. Fields RA, Toubbeh H, Searles RP, Bankhurst AD: The prevalencc of anticardiolipin antibodies in a healthy el-derly population and its association witb antinuclear anti-bodies.J Rhcumatol 16: 623 (1989).
Sirozlu Hastalarda Aütikardiyolipin Antikorları
5. Galli M, Finazzi G, Barnui T: Tbrombocytopenia in the antiphospholipid syııdrome. Br J Haematol 93: 1 (1996)
6. Gleicner N, Coulam C: Letter. Lancct 354:72 (1999).
7. Greaves M.: Antiphospholipid antibodies and thrombo-sis. Lancet 353:1348(1999).
8. Goulis S, Chau TN, Jordan S, ct al: Thrombopoietin con-centrations are low in patients with cirrhosis and thrombocytopenia and are restored aftcr orthotopic liver trans-plantation. Gut 44: 754 (1999).
9. Handin RI.: Disorders of coagulation and thrombosis. "Harrison's Principles of International Mcdicine, editörler: Fauci SA, Braunwald E, Isselbacher KJ, vc ark, Mc-Graw Hill, 14üı edition, NewYork,". s:736 (1998).
10. Harris EN, Gharavi AE, Hedge U, et al: Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59:231 (1985).
[ i. Hughes GRV: The antiphospholipid syndrome: ten years on. Lancet 342: 341 (1993).
12. Hughes GRV, Harris EN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol 13: 586 (1986).
13. Juby A, Davis P, Genge T, McElhaney J: Anticardiolipin antibodies in two eiderly subpopuiations. Lupus 4: 482 (1995).
14. Mangia A, Margaglione M, Cascavilla 1, et al.: Anticardiolipin antibodies in patients wiîh liver disease. Am J Gastroenteıol 94: 2983 (1999).
15. Prieto J, Yustc JR, BeIoqui O, et al.: Anticardiolipin Antibodies in Chronic Hepatitis C: Implication of Hepatitis C virüs as thc cause of the aniiphopholipid Syndrome. Hepatology 23: 199 (1996).
İ 6. Cjuintarelîİ C, Ferro D, Valesini G, et al.: Prevalence of lupus anticoagulant in patient with cirrhosis: relationship with beta-2-glycoprotein I levels. J Hepatol 21: 1086 (1994).
17. Rulîatti A, Rossi L, Calligaro A, et al: Autoanfibodİes of syslcmic rheumatic diseases in thc hcalthy eiderly. Ge-rontology 36:104(1990).
18. Sherlock S, Dooley J: Disease of Liver and Biliary System. Blackvvell Scientific Publications, Oxford, 9th edition (1993), p: 357.
19". Talenti DA, Faik GW, Carey VVD, Marchant K.: Anticardiolipin Anübody-Associated Infarction in Cirrhosis: Clcarancc of Anticardiolipin Antibody aller Liver Tıans-plantation. Am J Gatroenterol 89: 785 (1994).
20. Violi F, Ferro D, Quintarelli C, et al.: Dilutc aPTT Pro-longation by Antiphopholipid Antibodies in Patients wilh Liver Cirrhosis. Thromb Haemost 63: 183 (1990).

Thank you for copying data from http://www.arastirmax.com